Management of common sleep disorders.
Study Goal
The researchers aimed to evaluate the role of melatonin in treating rapid eye movement sleep behavior disorder (RBD).
Results Summary
Melatonin was found to be an effective treatment option for RBD, alongside environmental safety measures and clonazepam, by reducing harmful dream enactment behaviors.
Population
Patients with rapid eye movement sleep behavior disorder.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
cognitive behavior therapy | decrease | insomnia | patients with insomnia | - | treated | #1 |
sleep hypnotics | decrease | insomnia | patients with insomnia | - | treated | #2 |
treatment based on symptom frequency | decrease | Restless legs syndrome | patients with Restless legs syndrome | - | treated | #3 |
stimulants, such as modafinil | decrease | Narcolepsy | patients with Narcolepsy | - | treated | #4 |
selective serotonin reuptake inhibitors | decrease | Narcolepsy | patients with Narcolepsy | - | treated | #5 |
gamma hydroxybutyric acid (sodium oxybate) | decrease | Narcolepsy | patients with Narcolepsy | - | treated | #6 |
Continuous positive airway pressure | decrease | obstructive sleep apnea | patients with obstructive sleep apnea | - | most common and effective treatment | #7 |
environmental safety measures | decrease | Rapid eye movement sleep behavior disorder | patients with Rapid eye movement sleep behavior disorder | - | treated | #8 |
melatonin | decrease | Rapid eye movement sleep behavior disorder | patients with Rapid eye movement sleep behavior disorder | - | treated | #9 |
clonazepam | decrease | Rapid eye movement sleep behavior disorder | patients with Rapid eye movement sleep behavior disorder | - | treated | #10 |
Sleep disorders are common and affect sleep quality and quantity, leading to increased morbidity. Patients with sleep disorders can be categorized as those who cannot sleep, those who will not sleep, those with excessive daytime sleepiness, and those with increased movements during sleep. Insomnia, defined as difficulty initiating or maintaining sleep that results in daytime impairment, is diagnosed using history findings and treated with cognitive behavior therapy, with or without sleep hypnotics. Restless legs syndrome is characterized by an urge to move the legs that worsens with rest, is relieved by movement, and often occurs in the evening or at night. Restless legs syndrome is treated based on the frequency of symptoms. Narcolepsy is characterized by excessive sleepiness, cataplexy, hypnagogic or hypnopompic hallucinations, and sleep paralysis. It is diagnosed using a sleep log or actigraphy, followed by overnight polysomnography and a multiple sleep latency test. Narcolepsy is treated with stimulants, such as modafinil; selective serotonin reuptake inhibitors; or gamma hydroxybutyric acid (sodium oxybate). Patients with snoring and witnessed apneas may have obstructive sleep apnea, which is diagnosed using overnight polysomnography. Continuous positive airway pressure is the most common and effective treatment for obstructive sleep apnea. Rapid eye movement sleep behavior disorder is characterized by increased muscle tone during rapid eye movement sleep, resulting in the patient acting out dreams with possible harmful consequences. It is diagnosed based on history and polysomnography findings, and treated with environmental safety measures and melatonin or clonazepam.